Loading market data...
Saturday, August 29, 2026
LineVest LogoLineVest

LineVest

News

Latest U.S. market & finance news

News
Trian Circles Wendy's Again: What a Take-Private Bid Means for WEN Shareholders
News

Trian Circles Wendy's Again: What a Take-Private Bid Means for WEN Shareholders

Trian Fund (16% stake) prepares a take-private bid for Wendy's with BlueFive Capital and Flynn Group. The $4.1B debt load and 7.33x leverage make the LBO math complex.

2026.08.12.7
Goldman Sachs Agrees to Acquire ETF Provider NEOS Investments for Up to $2.25 Billion
News

Goldman Sachs Agrees to Acquire ETF Provider NEOS Investments for Up to $2.25 Billion

Goldman Sachs agreed to acquire NEOS Investments for up to $2.25B, adding $30B in options-income ETFs and targeting 8th-largest active ETF manager status.

2026.08.12.12
Super Micro Computer (SMCI) Q4 FY2026: Margin Soars to 17.6%, FY2027 Guidance of $65B–$72B Tops All Forecasts
News

Super Micro Computer (SMCI) Q4 FY2026: Margin Soars to 17.6%, FY2027 Guidance of $65B–$72B Tops All Forecasts

Super Micro's Q4 FY2026 non-GAAP gross margin soared to 17.6% vs 8.4% guidance, while FY2027 revenue guidance of $65B–$72B dwarfs the $54.4B Bloomberg consensus.

2026.08.12.9
Chipotle's 'Guac Signal' Outpaced the FDA on Jalapeño Recall — CMG Shares Down 15% From Post-Q2 High
News

Chipotle's 'Guac Signal' Outpaced the FDA on Jalapeño Recall — CMG Shares Down 15% From Post-Q2 High

Chipotle's 'Guac Signal' traced tainted jalapeños before the company-level recall; CMG is down 15% from post-Q2 highs as 345 CDC-confirmed illnesses span 27 states.

2026.08.12.6
Teledyne to Acquire Varex Imaging for $1.1 Billion in All-Cash Deal, 52% Premium
News

Teledyne to Acquire Varex Imaging for $1.1 Billion in All-Cash Deal, 52% Premium

Teledyne Technologies offers $18.90 per share in cash for Varex Imaging—a 52.3% premium over Friday's close—to expand its medical and industrial X-ray imaging capabilities.

2026.08.12.9
Meta Forced to Unwind $2 Billion Manus AI Deal as China's NDRC Orders Reversal
News

Meta Forced to Unwind $2 Billion Manus AI Deal as China's NDRC Orders Reversal

China forced Meta to unwind its $2B Manus AI acquisition. Manus returns as independent company August 2026. What Beijing's intervention means for META stock and AI M&A risk.

2026.08.12.7
NextEra Energy Files Dominion H1 2026 Financials With SEC as $66.8B Merger Heads to September 3 Vote
News

NextEra Energy Files Dominion H1 2026 Financials With SEC as $66.8B Merger Heads to September 3 Vote

NextEra Energy filed Dominion H1 2026 financials in an 8-K before Sept. 3 votes on the $66.8B deal. Dominion Q2: $4.48B revenue, $0.79 EPS, 6th straight beat; ~10% arb spread.

2026.08.11.4
ICE Kicks Off $3.5B Bond Sale to Fund $6B MarketAxess Acquisition
News

ICE Kicks Off $3.5B Bond Sale to Fund $6B MarketAxess Acquisition

ICE launched a $3.5B bond sale Aug 11 to fund its $6B MarketAxess deal, creating a ~23% fixed-income market share platform — nearly matching Tradeweb at ~24%.

2026.08.11.5
NVIDIA Recruits Six Wall Street Giants for $500 Billion AI Compute Financing Push
News

NVIDIA Recruits Six Wall Street Giants for $500 Billion AI Compute Financing Push

NVIDIA signed MOUs with six Wall Street giants to mobilize over $500B for AI infrastructure, treating GPU compute as investable collateral — subject to final agreements.

2026.08.11.7
Moderna's mFlusiva Wins FDA Approval as First-Ever mRNA Flu Vaccine After Six-Month Regulatory Saga
News

Moderna's mFlusiva Wins FDA Approval as First-Ever mRNA Flu Vaccine After Six-Month Regulatory Saga

FDA cleared Moderna's mFlusiva Aug. 5 — first mRNA flu vaccine. 26.6% rVE vs standard shots; ACIP frozen and 2026 contracting missed, so revenue likely delayed to 2027.

2026.08.11.6
Honeywell Aerospace (HONA) Q2 2026 Earnings Miss: Casting Shortage Caps Engine Growth, Stock Falls 23%
News

Honeywell Aerospace (HONA) Q2 2026 Earnings Miss: Casting Shortage Caps Engine Growth, Stock Falls 23%

HONA Q2 EPS missed 12% ($1.87 vs $2.13); guidance cut on casting shortage. Stock -23% on Aug 6 to $157, ~$163 by Aug 11. Analyst avg target $253 implies 55% upside.

2026.08.11.1
Jefferies Cuts Apple to Underperform as All-Glass iPhone Faces Cancellation Risk, Sell Ratings Hit 2012 Level
News

Jefferies Cuts Apple to Underperform as All-Glass iPhone Faces Cancellation Risk, Sell Ratings Hit 2012 Level

Jefferies downgrades Apple to Underperform, PT ~USD 264, on possible all-glass iPhone cancellation and 38% BOM inflation. At least 6 sell ratings match a 2012 level.

2026.08.11.5